CKLSF (CK Life Sciences International Holdings) Revenue: $692.4 Mil (TTM As of Dec. 2025)


CKLSF CK Life Sciences International Holdings Inc CKLSF
34 GF Score
Price $0.09
GF Value $0.11
! 5 Warning Signs
View Full Analysis

What is CK Life Sciences International Holdings Revenue?

CK Life Sciences International Holdings CKLSF +28.57% 34 Revenue is $692.4 Mil as of Dec. 2025. GuruFocus rates CKLSF with a GF Score™ of 34/100 and a GF Value™ of $0.11. The stock has 5 warning signs investors should review.

CK Life Sciences International Holdings's revenue for the six months ended in Dec. 2025 was $360.4 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $692.4 Mil. CK Life Sciences International Holdings's Revenue per Share for the six months ended in Dec. 2025 was $0.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.07.

Warning Sign:

CK Life Sciences International Holdings Inc revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of CK Life Sciences International Holdings was -2.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, CK Life Sciences International Holdings's highest 3-Year average Revenue per Share Growth Rate was 357.90% per year. The lowest was -1.80% per year. And the median was 2.70% per year.


CK Life Sciences International Holdings  (OTCPK:CKLSF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


CK Life Sciences International Holdings Revenue Related Terms


CK Life Sciences International Holdings Revenue Historical Data

* Premium members only.

The historical data trend for CK Life Sciences International Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CK Life Sciences International Holdings Revenue Chart

CK Life Sciences International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 692.69 677.63 681.55 710.46 695.33

CK Life Sciences International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 351.30 337.50 371.37 332.01 360.43

CKLSF vs VRTX, REGN, ALNY: Revenue Comparison

For the Biotechnology subindustry, CK Life Sciences International Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings Revenue vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Revenue falls into.


CKLSF
34GF Score
CK Life Sciences International Holdings Inc CKLSF
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CK Life Sciences International Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $692.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $692.4 Mil mean?
CK Life Sciences International Holdings (CKLSF) has a Revenue of $692.4 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on CK Life Sciences International Holdings and its competitors.
Is CK Life Sciences International Holdings' Revenue too high?
CK Life Sciences International Holdings' current Revenue is $692.4 Mil. Overall, CK Life Sciences International Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Revenue compare to VRTX and REGN?
CK Life Sciences International Holdings' Revenue of $692.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Biotechnology company?
A good Revenue depends on the Biotechnology industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on CK Life Sciences International Holdings and its competitors. CK Life Sciences International Holdings's current Revenue is $692.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (CKLSF) has a current Revenue of $692.4 Mil. The stock's GF Value™ is $0.11, compared to a current price of $0.09 — trading 18.2% below its estimated fair value. The current Revenue is $692.4 Mil. CK Life Sciences International Holdings' overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For CK Life Sciences International Holdings (CKLSF), the current Revenue is $692.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CK Life Sciences International Holdings (CKLSF) Overvalued in 2026?

Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued. The current stock price of $0.09 is trading 18.2% below its estimated GF Value™ of $0.11.

Key valuation signals for CKLSF:

  • Revenue: $692.4 Mil
  • GF Value™: $0.11 vs. price of $0.09 (18.2% below fair value)
  • GF Score™: 34/100 with 5 warning signs

No single metric tells the full story. See the CKLSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CK Life Sciences International Holdings Business Description

Other Exchanges 00775:Hong Kong
Address 2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score

Get the complete analysis for CKLSF

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price
$0.11
GF Value